Cerus (Nasdaq: CERS) is expected to report Q1 earnings on April 30. Here's what Wall Street wants to see:

The 10-second takeaway
 Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Cerus's revenues will expand 15.0% and EPS will remain in the red.

The average estimate for revenue is $10.1 million. On the bottom line, the average EPS estimate is -$0.08.

Revenue details
 Last quarter, Cerus chalked up revenue of $10.5 million. GAAP reported sales were 1.0% higher than the prior-year quarter's $10.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
 Last quarter, non-GAAP EPS came in at -$0.03. GAAP EPS were -$0.07 for Q4 against -$0.16 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Recent performance
 For the preceding quarter, gross margin was 51.4%, much better than the prior-year quarter. Operating margin was -34.2%, 220 basis points worse than the prior-year quarter. Net margin was -16.3%, much better than the prior-year quarter.

Looking ahead

The full year's average estimate for revenue is $43.0 million. The average EPS estimate is -$0.29.

Investor sentiment
 The stock has a two-star rating (out of five) at Motley Fool CAPS, with 130 members out of 150 rating the stock outperform, and 20 members rating it underperform. Among 33 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 23 give Cerus a green thumbs-up, and 10 give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Cerus is buy, with an average price target of $5.30.

Is Cerus the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.